Clinical trial · Interventional
Exercise During the Allogeneic Stem Cell Transplantation
NCT00883714CI-TRIAL-00002917unknownPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study will evaluate the effects of a structured endurance exercise program on the physical performance, the mood and the complications of patients with hematological malignancies undergoing a high-dose chemotherapy followed by an allogeneic peripheral blood stem cell transplantation.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Allogeneic Stem Cell Transplantation | — | UNRESOLVED | — |
| Fatigue | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise Instruction | Other | — | UNRESOLVED |
| Supervised exercise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Supervised exercise
- interventionNames
- Other: Supervised exercise
- type
- ACTIVE_COMPARATOR
- label
- Control group
- interventionNames
- Other: Exercise Instruction
Primary outcomes (1)
- measure
- VO2max
- timeFrame
- At recruitment and after 4 weeks
Secondary outcomes (3)
- measure
- Complications
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Neoplastic malignancy * Allogeneic peripheral stem cell transplantation * Proficiency in German Exclusion Criteria: * Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise * Pathological stress-ECG at admission
References
Publications (0)
Data not yet available
No reference posted for this study.